Steve P. Watson

Active 1982–2025

185
Papers
23,167
Citations
98
h-index
181
i10-index

Citations

Citations per year for Steve P. Watson1979: 1 citations1982: 1 citations1983: 2 citations1985: 22 citations1986: 41 citations1987: 31 citations1988: 29 citations1989: 30 citations1990: 24 citations1991: 26 citations1992: 20 citations1993: 24 citations1994: 22 citations1995: 36 citations1996: 35 citations1997: 78 citations1998: 108 citations1999: 161 citations2000: 139 citations2001: 147 citations2002: 125 citations2003: 213 citations2004: 183 citations2005: 170 citations2006: 140 citations2007: 149 citations2008: 131 citations2009: 178 citations2010: 181 citations2011: 175 citations2012: 160 citations2013: 203 citations2014: 183 citations2015: 213 citations2016: 150 citations2017: 185 citations2018: 141 citations2019: 654 citations2020: 724 citations2021: 734 citations2022: 561 citations2023: 336 citations2024: 527 citations2025: 221 citations2026: 1 citations1980–1981: no citations, so these years are not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,772 citing papers, 26.1% of this breakdownUnited Kingdom: 797 citing papers, 11.8% of this breakdownGermany: 635 citing papers, 9.4% of this breakdownChina: 433 citing papers, 6.4% of this breakdownFrance: 390 citing papers, 5.8% of this breakdownNetherlands: 285 citing papers, 4.2% of this breakdownCanada: 246 citing papers, 3.6% of this breakdownItaly: 237 citing papers, 3.5% of this breakdownJapan: 237 citing papers, 3.5% of this breakdownAustralia: 217 citing papers, 3.2% of this breakdownSpain: 145 citing papers, 2.1% of this breakdownSwitzerland: 103 citing papers, 1.5% of this breakdown
0%26.1%Other 18.9%

Fields

  • Medicine60.1%
  • Biochemistry, Genetics and Molecular Biology24.2%
  • Immunology and Microbiology7.6%
  • Neuroscience2.6%
  • Materials Science0.8%
  • Agricultural and Biological Sciences0.8%
  • Other3.9%

Topics

  • Platelet Disorders and Treatments11.1%
  • Cell Adhesion Molecules Research3.5%
  • Antiplatelet Therapy and Cardiovascular Diseases3.2%
  • Blood Coagulation and Thrombosis Mechanisms2.4%
  • Blood properties and coagulation2.2%
  • Protein Kinase Regulation and GTPase Signaling2.2%
  • Other75.4%

Coauthors

All papers

Open in search
  1. S100A8/A9 drives the formation of procoagulant platelets through GPIbα

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 104

  2. Platelet-collagen interaction: is GPVI the central receptor?

    Authors: , - Blood 2003 cited by 1,143

  3. Functional significance of the platelet immune receptors GPVI and CLEC-2

    Authors: , , - Journal of Clinical Investigation 2019 cited by 315

  4. The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation

    Authors: , , , - Research and Practice in Thrombosis and Haemostasis 2019 cited by 187

  5. DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets

    Authors: , , , , , , , , , , , , , , , , - Journal of Virology 2006 cited by 266

  6. Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activation

    Authors: , , - Journal of Thrombosis and Haemostasis 2011 cited by 304

  7. Understanding Infection-Induced Thrombosis: Lessons Learned From Animal Models

    Authors: , , , , , - Frontiers in Immunology 2019 cited by 214

  8. The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure

    Authors: , , , , , , , , , , , , , , - Nature Communications 2020 cited by 85

  9. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH

    Authors: , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2013 cited by 547

  10. Heme induces human and mouse platelet activation through C-type-lectin-like receptor-2

    Authors: , , , , , , , , - Haematologica 2020 cited by 79

  11. Fibrin activates GPVI in human and mouse platelets

    Authors: , , , , , , - Blood 2015 cited by 257

  12. Platelet Lipidomics

    Authors: , , - Circulation Research 2014 cited by 159

  13. PF4 activates the c-Mpl–Jak2 pathway in platelets

    Authors: , , , , , , - Blood 2023 cited by 42

  14. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis

    Authors: , , , - Blood 2017 cited by 187

  15. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis

    Authors: , , , , , , , , , - Nature Communications 2017 cited by 144

  16. Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib

    Authors: , , , , , , , , - Therapeutic Advances in Hematology 2021 cited by 62

  17. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen

    Authors: , , - Current Biology 1998 cited by 253

  18. Appropriation of GPIbα from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2019 cited by 97

  19. Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System

    Authors: , , , - Arteriosclerosis Thrombosis and Vascular Biology 2021 cited by 78

  20. GPVI and integrin αIIbβ3 signaling in platelets

    Authors: , , , - Journal of Thrombosis and Haemostasis 2005 cited by 417

  21. Dual role of collagen in factor XII–dependent thrombus formation

    Authors: , , , , , , , , , - Blood 2009 cited by 236

  22. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development

    Authors: , , , , , , , , , , , , , , , - Blood 2011 cited by 154

  23. Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Mumford, M. E. Daly, Steve P. Watson, Neil V. Morgan, on behalf of the UK GAPP Study Group - Haematologica 2016 cited by 142

  24. Fibrin-glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure

    Authors: , , , , , , , , - Journal of Thrombosis and Haemostasis 2023 cited by 57